Opko Health, Inc.
OPK
$1.29
-$0.015-1.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.78% | -17.41% | -17.94% | -17.48% | -12.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.78% | -17.41% | -17.94% | -17.48% | -12.38% |
| Cost of Revenue | -5.36% | -5.53% | -0.03% | -4.50% | -11.59% |
| Gross Profit | -42.34% | -50.42% | -64.80% | -54.79% | -14.93% |
| SG&A Expenses | -0.66% | 1.22% | 2.78% | -8.09% | -10.79% |
| Depreciation & Amortization | -5.74% | -3.95% | -2.70% | -1.27% | -1.42% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.01% | -3.41% | 0.58% | -5.30% | -10.56% |
| Operating Income | -35.25% | -73.07% | -108.98% | -56.45% | 2.44% |
| Income Before Tax | 99.77% | 94.37% | 44.96% | 6.67% | 24.58% |
| Income Tax Expenses | 1,972.44% | 865.58% | 343.56% | 97.03% | 104.52% |
| Earnings from Continuing Operations | 84.55% | 71.82% | 35.58% | -16.19% | 13.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.55% | 71.82% | 35.58% | -16.19% | 13.32% |
| EBIT | -35.25% | -73.07% | -108.98% | -56.45% | 2.44% |
| EBITDA | -83.70% | -232.41% | -394.77% | -153.41% | 2.44% |
| EPS Basic | 82.79% | 70.51% | 33.68% | -18.95% | 13.28% |
| Normalized Basic EPS | 84.43% | 73.37% | -2.51% | 23.84% | 29.64% |
| EPS Diluted | 80.87% | 68.04% | 31.22% | -19.95% | 12.57% |
| Normalized Diluted EPS | 81.58% | 69.36% | 10.90% | 23.84% | 29.64% |
| Average Basic Shares Outstanding | -7.48% | -7.68% | -5.15% | -3.22% | -0.10% |
| Average Diluted Shares Outstanding | 12.07% | 11.58% | 4.96% | -3.22% | -0.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |